Skip to search formSkip to main contentSkip to account menu

Copeptin Measurement

Known as: COPEP, Copeptin 
The determination of the amount of copeptin present in a sample.
National Institutes of Health

Related topics

Related topics

5 relations
AVP geneCDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The diagnostic value of serum copeptin levels in an acute pulmonary embolism.
BACKGROUND Acute pulmonary embolism (APE) is a common disease which is associated with high mortality and morbidity. Circulating… 
2015
2015
Copeptin (C-terminal pro arginine-vasopressin) is an independent long-term prognostic marker in heart failure with reduced ejection fraction.
2014
2014
Copeptin, a surrogate marker for arginine vasopressin secretion, is associated with higher glucose and insulin concentrations but not higher blood pressure in obese men
To explore the putative associations of plasma copeptin, the C‐terminal portion of provasopressin and a surrogate marker for… 
2014
2014
Plasma copeptin levels are associated with prognosis of severe acute pancreatitis
Review
2013
Review
2013
Additional diagnostic and prognostic value of copeptin ultra-sensitive for diagnosis of non-ST-elevation myocardial infarction in older patients presenting to the emergency department
Abstract Background: Identifying older patients with non-ST- elevation myocardial infarction (NSTEMI) within the very large… 
Highly Cited
2012
Highly Cited
2012
Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease.
2012
2012
Copeptin: a marker for stress reaction in fetuses with intrauterine growth restriction.
2009
2009
Response of Novel Biomarkers to BNP Infusion in Patients with Decompensated Heart Failure: A Multimarker Paradigm
Multibiomarker paradigms have been proposed to diagnose, define progression, and to monitor therapy of heart failure (HF… 
1997
1997
Interactions of deglycosylated cobalt(III)-pepleomycin (green form) with DNA based on NMR structural studies,.
Pepleomycin (PEP)1 is a metalloglycopeptide antitumor antibiotic that has improved pharmacological properties than does bleomycin… 
1997
1997
Structures of cobalt(III)-pepleomycin and cobalt(III)-deglycopepleomycin (green forms) determined by NMR studies.
Pepleomycin (PEP) is a metalloglycopeptide that has stronger anticancer activity and less pulmonary toxicity than bleomycin (BLM… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)